Hiru Corporation (OTCPK:HIRU)
HIRU and its main subsidiary Jiangxi Shuangshi Animal Health Products Co. (Shuangshi AHP Co.) focus on the development, manufacturing and marketing of a broad range of veterinary products for the Chinese Agricultural market.
HIRU’s subsidiary Shuangshi AHP has established a strong position in the Chinese animal husbandry market and plans to expand and deliver more new products and solutions to this market in the future.
HIRU’s subsidiary Shuangshi AHP Co. is devoted to the protection of animal and human health. The company employs scientists, highly trained technical experts, engineers and veterinarians whose innovative spirit offers services for the improvement of the animal husbandry. The company focuses on all species and a wide range of breeding situations. The company is able to adapt products to any customer specific needs.
Shuangshi AHP provides the Chinese agricultural market with veterinary and animal nutrition solutions which include large volume injections, liquid disinfectants and feed additives.
Shaungshi AHP has launched recently the Jiangxi Shaungshi Biological Medicines Institute.
HIRU’s subsidiary Shuangshi AHP is currently researching several new veterinary drugs for development within the next two years. The company launched this new institute to strengthen and speed up the research and development processes. The Institute will allow the company a better focus and concentration of its talent in bio-tech development and research.
The company intends to continue its work in the development, production and marketing of both well-established and new veterinary drugs, and nutritional additives (amino acids, vitamins, trace elements, etc.) for the Chinese market.
Hiru Corporation operates through its subsidiary, Jiangxi RongYu Pharmaceutical Group Inc., is a producer of Chinese herbs for the naturopathic industry in China. Jiangxi RongYu Pharmaceutical Group Co., Ltd. focuses on producing and manufacturing of herbs, herbal extracts and herbal preparations. HIRU's products are based on the traditional Chinese systems. HIRU researches and develops dosage approaches and health applications of these traditional recipes. On December 3, 2009, HIRU completed the merger with the China-based company Jiangxi RongYu Pharmaceutical Group Inc.
To learn more about HIRU visit: http://www.hirucorporation.com
Brightpoint, Inc. (Nasdaq:CELL) reported that its board of directors has approved the increase of its previously announced share repurchase plan by an additional $25 million (”Amended Share Repurchase Program”).
The Amended Share Repurchase Program was increased to an aggregate of $130 million from the existing $105 million. Under the Amended Share Repurchase Program a total of up to an additional $36.6 million of share repurchases will be available based upon the existing $11.6 million remaining available under the previously existing share repurchase program.
The issued and outstanding common stock repurchased under the Amended Share Repurchase Program shall be designated as Treasury Shares, and may be effected from time to time depending on market conditions through open market or privately negotiated transactions or otherwise in accordance with, and subject to, the provisions of Rule 10(b)-18.
The Amended Share Repurchase Program will expire on December 31, 2012.
A123 Systems (Nasdaq:AONE), a developer and manufacturer of advanced Nanophosphate™ lithium ion batteries and systems, reported its financial results for the quarter ended September 30, 2010.
Total revenue for the third quarter of 2010 was $26.2 million, compared to $23.6 million for the third quarter of 2009. Within total revenue, product revenue was $19.0 million, compared to $20.0 million in the third quarter of 2009, and services revenue was $7.3 million, compared to $3.6 million in the third quarter of 2009.
For the nine months ended September 30, 2010, A123 Systems reported total revenue of $73.3 million, an increase of 10% compared to revenue of $66.5 million in the same period in 2009. For the nine months ended September 30, 2010, product revenue was $54.3 million, compared to $56.6 million in the same period of 2009, and services revenue was $19.0 million, compared to $9.9 million in the same period of 2009.
Gross loss was ($3.1) million in the third quarter of 2010, compared to a gross loss of ($1.9) million in the third quarter of 2009. For the nine months ended September 30, 2010, gross loss was ($8.1) million, compared to ($2.6) million in the same period of 2009.
Net loss was ($43.7) million, or ($0.42) per common share, based on 104.7 million weighted average common shares outstanding in the third quarter of 2010. This compared to a net loss of ($22.8) million in the third quarter of 2009, or ($1.78) per common share, based on 12.8 million weighted average common shares outstanding.
AutoZone, Inc. (NYSE:AZO), the nation’s leading auto parts retailer and a leading distributor of automotive replacement parts and accessories, reported that it will release results for its first quarter ended Saturday, November 20, 2010, before market open on Tuesday, December 7, 2010.
Additionally, AZO will host a one hour conference call on Tuesday, December 7, 2010, beginning at 10:00 a.m. (EST), to discuss the results of the quarter.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (OTCPK:HIRU)